EUVIMEDEUVIMED entdecken
Open Access

Chitinase 3–like-1 Inhibits Innate Antitumor and Tissue Remodeling Immune Responses by Regulating CD47-SIRPα– and CD24-Siglec10–Mediated Phagocytosis

Bing Ma iD, Suchitra Kamle iD, Takayuki Sadanaga iD, Chang-Min Lee iD, Joyce H Lee iD, Daniel C Yee, Zhou Zhu, Edwin K Silverman, Dawn L DeMeo, Augustine M K Choi, Chun Geun Lee iD, Jack A Elias iD

The Journal of Immunology · 2024

DOI: 10.4049/jimmunol.2400035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Bing Ma und 11 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Microbiology and Immunology, Brown University, Providence, RI. Hauptthemen laut MEDLINE: Phagocytosis, CD47 Antigen, Immunity, Innate, Chitinase-3-Like Protein 1. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: U.S. Department of Defense (DOD), HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Innate immune responses such as phagocytosis are critically linked to the generation of adaptive immune responses against the neoantigens in cancer and the efferocytosis that is essential for homeostasis in diseases characterized by lung injury, inflammation, and remodeling as in chronic obstructive pulmonary disease (COPD). Chitinase 3–like-1 (CHI3L1) is induced in many cancers where it inhibits adaptive immune responses by stimulating immune checkpoint molecules (ICPs) and portends a poor prognosis. CHI3L1 is also induced in COPD where it regulates epithelial cell death. In this study, we demonstrate that pulmonary melanoma metastasis inhibits macrophage phagocytosis by stimulating the CD47-SIRPα and CD24-Siglec10 phagocytosis checkpoint pathways while inhibiting macrophage “eat me” signals from calreticulin and HMGB1. We also demonstrate that these effects on macrophage phagocytosis are associated with CHI3L1 stimulation of the SHP-1 and SHP-2 phosphatases and inhibition of the accumulation and phosphorylation of cytoskeleton-regulating nonmuscle myosin IIa. This inhibition of innate immune responses such as phagocytosis provides a mechanistic explanation for the ability of CHI3L1 to stimulate ICPs and inhibit adaptive immune responses in cancer and diseases such as COPD. The ability of CHI3L1 to simultaneously inhibit innate immune responses, stimulate ICPs, inhibit T cell costimulation, and regulate a number of other oncogenic and inflammation pathways suggests that CHI3L1-targeted therapeutics are promising interventions in cancer, COPD, and other disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhagocytosisCD47 AntigenImmunity, InnateChitinase-3-Like Protein 1Receptors, ImmunologicAnimalsMiceMice, Inbred C57BLMacrophagesCD24 AntigenLung NeoplasmsAntigens, DifferentiationHumansLectinsCell Line, Tumor

Substanzen

CD47 AntigenChitinase-3-Like Protein 1Chil1 protein, mouseReceptors, ImmunologicCD24 AntigenAntigens, DifferentiationSirpa protein, mouseCd47 protein, mouseLectins

Autor:innen und Institutionen

  • Molecular Microbiology and Immunology, Brown University, Providence, RI.
  • Johns Hopkins School of Medicine, Baltimore, MD.
  • Division of Pulmonary, Allergy and Critical Care Medicine, Columbia University Medical Center, New York, NY.
  • Department of Pediatrics, Brown University, Providence, RI.
  • Channing Division of Network Medicine, Brigham and Woman's Hospital, Harvard Medical School, Boston, MA.
  • Department of Medicine, Weill Cornell Medical School, New York, NY.

ORCID-Profile: Bing Ma, Suchitra Kamle, Takayuki Sadanaga, Chang-Min Lee, Joyce H Lee, Chun Geun Lee, Jack A Elias

Förderung

  • U.S. Department of Defense (DOD)
  • HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
  • NHLBI NIH HHS

Zitieren

APA

Ma, B., Kamle, S., Sadanaga, T., Lee, C. M., Lee, J. H., Yee, D. C., Zhu, Z., Silverman, E. K., DeMeo, D. L., Choi, A. M. K., Lee, C. G., & Elias, J. A. (2024). Chitinase 3–like-1 Inhibits Innate Antitumor and Tissue Remodeling Immune Responses by Regulating CD47-SIRPα– and CD24-Siglec10–Mediated Phagocytosis. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2400035

Vancouver

Ma B, Kamle S, Sadanaga T, Lee CM, Lee JH, Yee DC, et al. Chitinase 3–like-1 Inhibits Innate Antitumor and Tissue Remodeling Immune Responses by Regulating CD47-SIRPα– and CD24-Siglec10–Mediated Phagocytosis. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2400035

BibTeX
@article{Ma2024,
  author = {Ma, Bing and Kamle, Suchitra and Sadanaga, Takayuki and Lee, Chang-Min and Lee, Joyce H and Yee, Daniel C and Zhu, Zhou and Silverman, Edwin K and DeMeo, Dawn L and Choi, Augustine M K and Lee, Chun Geun and Elias, Jack A},
  title = {Chitinase 3–like-1 Inhibits Innate Antitumor and Tissue Remodeling Immune Responses by Regulating CD47-SIRPα– and CD24-Siglec10–Mediated Phagocytosis},
  journal = {The Journal of Immunology},
  year = {2024},
  doi = {10.4049/jimmunol.2400035}
}
Kostenlos starten →